October 2021 – Management of Burn Patients

October 14th, 2021 at Water’s Edge, Centerport

Sponsored Talk (Shionogi Inc.) – Fetroja® (cefiderocol): A Unique Siderophore Cephalosporin for the Treatment of Difficult-to-Treat Infections Due to Susceptible Gram-negative Pathogens

Memorie Shaw Wilcoxon, PharmD, BCPS

Educational Program – Fuel for Thought – Pharmacologic Management of Burn Patients

Matthew Li, PharmD, BCPS, BCCCP
Clinical Pharmacy Specialist – Trauma/Surgical/Burn ICU
Westchester Medical Center